{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-009002","form_type":"8-K","ticker":"PTN","cik":"0000911216","company_name":"PALATIN TECHNOLOGIES INC","filed_at":"2023-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.995287+00:00","generated_at":"2026-06-13T10:23:58.549160+00:00","sec_items":["8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Palatin prelim Q4 Vyleesi net revenue $1.7M, up 122% YoY; prescriptions +89% YoY","bullets":["Gross product revenue $4.1M, up 20% QoQ and 78% YoY.","Net product revenue $1.7M, up 42% QoQ and 122% YoY.","Prescriptions dispensed increased 14% QoQ and 89% YoY.","New healthcare prescribers up 20% QoQ; 6 consecutive quarters of double-digit growth.","Management states net revenue per prescription continues to improve, exceeding quarterly operating expenses."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-009002","json":"https://secwatch.observer/filing/0001654954-23-009002.json","markdown":"https://secwatch.observer/filing/0001654954-23-009002.md","text":"https://secwatch.observer/filing/0001654954-23-009002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/911216/000165495423009002/0001654954-23-009002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/911216/000165495423009002/ptn_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T10:23:58.549160+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}